Complete Genomics, Inc. (GNOM) Misses Q4 EPS by 2c

Complete Genomics, Inc. (NASDAQ: GNOM) reported Q4 EPS of ($0.67), $0.02 worse than the analyst estimate of ($0.65). Revenue for the quarter came in at $2.5 million versus the consensus estimate of $3.15 million.

Sees sequencing 1,100-1,300 genomes during Q1.

For earnings history and earnings-related data on Complete Genomics, Inc. (GNOM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Iridium Communications (IRDM) Reports In-Line Q1 EPS; offers outlook
• Home Bancshares (HOMB) Tops Q1 EPS by 3c
• B.Riley Starts Energy Fuels (UUUU) at Buy